Similar articles

• Immunosuppression with cyclosporine, azathioprine, and prednisolone in cadaver renal allograft recipients.

  Jones RM, Murie JA, Allen R, Jaskowski A, Morris PJ. Jones RM, et al. Transplant Proc. 1987 Feb;19(1 Pt 3):1926. Transplant Proc. 1987. PMID: 3274453 No abstract available.
• Postoperative endogenous serum cortisol levels as an index of acute rejection and severe infection in renal allograft recipients.

  Kozaki M, Hirano T, Oka K, Honma M, Kang X, Sakurai E, Tamaki T, Tamaki I. Kozaki M, et al. Transplant Proc. 1989 Feb;21(1 Pt 2):1864-6. Transplant Proc. 1989. PMID: 2652606 No abstract available.
• Conversion from azathioprine and/or prednisolone to cyclosporine A in renal allograft recipients.

  Ebel H, Lange H. Ebel H, et al. Transplant Proc. 1987 Feb;19(1 Pt 3):2005-6. Transplant Proc. 1987. PMID: 3274463 No abstract available.
• [New developments in the immunosuppressive treatment of patients following a kidney transplant].

  Beleva B, Filev A, Mladenov D. Beleva B, et al. Khirurgiia (Sofiia). 1986;39(2):47-9. Khirurgiia (Sofiia). 1986. PMID: 3525972 Review. Bulgarian. No abstract available.
• Triple therapy.

  Slapak M, Digard N, Wise M, Setakis N. Slapak M, et al. Transplant Proc. 1991 Aug;23(4):2186-8. Transplant Proc. 1991. PMID: 1871837 Review. No abstract available.